Literature DB >> 9845231

Serum leptin concentration and insulin sensitivity in men with abdominal obesity.

G Johannsson1, C Karlsson, L Lönn, P Mårin, P Björntorp, L Sjöström, B Carlsson, L M Carlsson, B A Bengtsson.   

Abstract

OBJECTIVE: We have examined the association between generalized adiposity, abdominal adiposity, insulin sensitivity, and serum levels of leptin in a cross-sectional study of abdominally obese men. RESEARCH METHODS AND PROCEDURES: Thirty men, 48 to 66 years of age with a body mass index (BMI) of between 25 kg/m2 and 35 kg/m2 and a waist hip ratio of >0.95, were included in the study. Serum leptin concentration was measured using radioimmunoassay. Total body fat percentage was determined from total body potassium, abdominal adiposity was measured by computed tomography, and the glucose disposal rate (GDR) was measured during an euglycemic, hyperinsulinemic glucose clamp.
RESULTS: Significant correlations were found between serum leptin concentration and BMI, percentage body fat, abdominal subcutaneous adipose tissue, serum insulin, GDR, and 24-hour urinary-free cortisol. In a multiple regression analysis, it was shown that abdominal subcutaneous adipose tissue, GDR, and BMI explained 72% of the variability of serum leptin concentration. GDR demonstrated an independent inverse correlation with serum leptin concentration. DISCUSSION: In abdominally obese men with insulin resistance, it was demonstrated that most of the individual variability in serum leptin concentration was explained by the amount of subcutaneous abdominal adipose tissue, insulin sensitivity, and BMI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845231     DOI: 10.1002/j.1550-8528.1998.tb00373.x

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  6 in total

1.  Daily hunger sensation and body compartments: II. Their relationships in obese patients.

Authors:  P Cugini; A Salandri; M Cilli; P Ceccotti; A Di Marzo; A Rodio; S Fontana; A M Pellegrino; G P De Francesco; S Coda; F De Vito; L Colosi; C M Petrangeli; C Giovannini
Journal:  Eat Weight Disord       Date:  1999-06       Impact factor: 4.652

2.  Fasting plasma leptin level is a surrogate measure of insulin sensitivity.

Authors:  Hasan Askari; Gunjan Tykodi; Jianmei Liu; Samuel Dagogo-Jack
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

3.  Serum levels of leptin, insulin, and lipids in relation to breast cancer in china.

Authors:  Cunzhi Han; Hong-Tao Zhang; Lili Du; Xiuying Liu; Jiexian Jing; Xianwen Zhao; Xuan Yang; Baoguo Tian
Journal:  Endocrine       Date:  2005-02       Impact factor: 3.633

4.  Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity.

Authors:  Eran Elinav; Leonora Niv-Spector; Meirav Katz; Tulin O Price; Mohammed Ali; Michal Yacobovitz; Gili Solomon; Shay Reicher; Jessica L Lynch; Zamir Halpern; William A Banks; Arieh Gertler
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

5.  Leptin levels in obese women with and without type 2 diabetes mellitus.

Authors:  Mehmet Akif Buyukbese; Ali Cetinkaya; Ramazan Kocabas; Aytekin Guven; Mehmet Tarakcioglu
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

6.  Behavior of insulin sensitivity and its relation to leptin and tumor necrosis factor-alpha in obese women undergoing liposuction: 6-month follow-up.

Authors:  José Antonio Robles-Cervantes; Esperanza Martínez-Abundis; Manuel González-Ortiz; Lázaro Cárdenas-Camarena; Eduardo Hernández-Salazar; Rafael Olvera-Ozuna
Journal:  Obes Surg       Date:  2007-09       Impact factor: 3.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.